Finance

Lists
Why is 544222 down 2,28%?
Dive Deeper
544222:BOM
Akums Drugs and Pharmaceuticals Ltd
714,35 ₹
-2,28%
(-16,70) 1D
19 қаз., 10:03:49 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 544222...
Open
735,75 ₹
High
737,05 ₹
Low
712,25 ₹
Mkt. cap
109,62 млрд
Avg. vol.
11,30 мың
Volume
4,06 мың
Dividend
0,14%
Quarterly dividend
0,25 ₹
Ex-dividend date
2026 ж. 03 шіл.
P/E ratio
37,50
52-wk high
839,25 ₹
52-wk low
410,10 ₹
EPS
19,05 ₹
No. of employees
7 мың
Open
735,75 ₹
High
737,05 ₹
Low
712,25 ₹
Mkt. cap
109,62 млрд
Avg. vol.
11,30 мың
Volume
4,06 мың
Dividend
0,14%
Quarterly dividend
0,25 ₹
Ex-dividend date
2026 ж. 03 шіл.
P/E ratio
37,50
52-wk high
839,25 ₹
52-wk low
410,10 ₹
EPS
19,05 ₹
No. of employees
7 мың
News stories
From web sources and news partners
Profile
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical Contract Development and Manufacturing Organization that serves both domestic and multinational pharmaceutical companies. The company was established in 2004 and became publicly listed on 6 August 2024. Wikipedia
About Akums Drugs and Pharmaceuticals Ltd
CEO-
Employees7,34 мың
Founded2004
Headquarters-
Sector-
Websiteakums.in
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
10,18 млрд
11,60 млрд
11,60 млрд
11,67 млрд
Cost of goods sold
5,93 млрд
6,79 млрд
7,37 млрд
6,45 млрд
Cost of revenue
5,93 млрд
6,79 млрд
7,37 млрд
6,45 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,89 млрд
1,89 млрд
2,37 млрд
2,01 млрд
Operating expense
3,68 млрд
3,74 млрд
3,09 млрд
3,88 млрд
Total operating expenses
9,61 млрд
10,52 млрд
10,46 млрд
10,33 млрд
Operating income
566,12 млн
1,07 млрд
1,14 млрд
1,34 млрд
Other non operating income
323,65 млн
343,28 млн
-942,12 млн
303,80 млн
EBT including unusual items
656,73 млн
995,66 млн
1,21 млрд
1,39 млрд
EBT excluding unusual items
656,73 млн
1,18 млрд
1,19 млрд
1,39 млрд
Income tax expense
229,77 млн
318,92 млн
398,74 млн
382,59 млн
Effective tax rate
34,99%
32,03%
32,89%
27,48%
Other operating expenses
1,41 млрд
1,45 млрд
319,86 млн
1,45 млрд
Net income
407,83 млн
663,17 млн
846,13 млн
1,00 млрд
Net profit margin
4,01%
5,72%
7,29%
8,57%
Earnings per share
2,66
5,14
-
6,53
Interest and investment income
-
-
1,10 млрд
-
Interest expense
-233,04 млн
-237,42 млн
-184,41 млн
-247,56 млн
Net interest expenses
-233,04 млн
-237,42 млн
912,36 млн
-247,56 млн
Depreciation and amortization charges
378,64 млн
396,49 млн
401,18 млн
410,65 млн
EBITDA
940,04 млн
1,42 млрд
1,49 млрд
1,69 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары